DE69024279D1 - Cytokine - Google Patents
CytokineInfo
- Publication number
- DE69024279D1 DE69024279D1 DE69024279T DE69024279T DE69024279D1 DE 69024279 D1 DE69024279 D1 DE 69024279D1 DE 69024279 T DE69024279 T DE 69024279T DE 69024279 T DE69024279 T DE 69024279T DE 69024279 D1 DE69024279 D1 DE 69024279D1
- Authority
- DE
- Germany
- Prior art keywords
- derivatives
- polypeptides
- mediators
- hybrid vectors
- dnas
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3061—Blood cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Hematology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Radar Systems Or Details Thereof (AREA)
- Control Of Driving Devices And Active Controlling Of Vehicle (AREA)
- Control Of Transmission Device (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB898915414A GB8915414D0 (en) | 1989-07-05 | 1989-07-05 | Novel cytokines |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69024279D1 true DE69024279D1 (de) | 1996-02-01 |
DE69024279T2 DE69024279T2 (de) | 1996-10-17 |
Family
ID=10659582
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69024279T Expired - Fee Related DE69024279T2 (de) | 1989-07-05 | 1990-06-26 | Cytokine |
Country Status (14)
Country | Link |
---|---|
US (2) | US5411882A (de) |
EP (1) | EP0412050B1 (de) |
JP (1) | JPH0356499A (de) |
AT (1) | ATE131873T1 (de) |
AU (1) | AU649226B2 (de) |
CA (1) | CA2020303A1 (de) |
DD (1) | DD298948A5 (de) |
DE (1) | DE69024279T2 (de) |
DK (1) | DK0412050T3 (de) |
ES (1) | ES2081960T3 (de) |
GB (1) | GB8915414D0 (de) |
GR (1) | GR3018521T3 (de) |
IE (1) | IE70519B1 (de) |
PT (1) | PT94575B (de) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0263072B1 (de) * | 1986-10-03 | 1994-03-23 | Ciba-Geigy Ag | Lymphokin-ähnliche Peptide |
EP0615451B1 (de) | 1992-05-26 | 2005-12-07 | Immunex Corporation | Neue zytokine die cd30 binden |
US6080407A (en) * | 1993-05-17 | 2000-06-27 | The Picower Institute For Medical Research | Diagnostic assays for MIF |
US6774227B1 (en) * | 1993-05-17 | 2004-08-10 | Cytokine Pharmasciences, Inc. | Therapeutic uses of factors which inhibit or neutralize MIF activity |
UY27304A1 (es) | 2001-05-24 | 2002-12-31 | Avanir Pharmaceuticals | Inhibidores del factor inhibidor de la migración de los macrófagos y métodos para su identificación |
TW200418829A (en) | 2003-02-14 | 2004-10-01 | Avanir Pharmaceutics | Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
WO2005021546A1 (en) * | 2003-08-22 | 2005-03-10 | Avanir Pharmaceuticals | Substituted naphthyridine derivatives as inhibitors of macrophage migration inhibitory factor and their use in the treatment of human diseases |
US7740856B2 (en) * | 2005-12-20 | 2010-06-22 | Isu Abxis Co., Ltd. | Effect of BST2 on inflammation |
US20080299128A1 (en) * | 2006-06-20 | 2008-12-04 | Myung Kim | Effect of Bst2 on inflammation |
KR100735800B1 (ko) | 2004-12-20 | 2007-07-06 | 이수앱지스 주식회사 | 세포간 부착을 억제하는 분자 |
US8329186B2 (en) * | 2004-12-20 | 2012-12-11 | Isu Abxis Co., Ltd | Treatment of inflammation using BST2 inhibitor |
JP2008534502A (ja) * | 2005-03-24 | 2008-08-28 | アバニール・ファーマシューティカルズ | マクロファージ遊走阻止因子の阻害剤としてのチエノピリジノン誘導体 |
MXPA05011139A (es) * | 2005-10-17 | 2007-04-17 | Concretos Translucidos S De R | Formulacion para obtener una mezcla de concreto conductivo. |
GB0605689D0 (en) * | 2006-03-21 | 2006-05-03 | Novartis Ag | Organic compounds |
US9249217B2 (en) * | 2010-12-03 | 2016-02-02 | Secretary, DHHS | Bispecific EGFRvIII x CD3 antibody engaging molecules |
WO2013050453A1 (en) | 2011-10-07 | 2013-04-11 | Baxter Healthcare S.A. | Oxmif as a diagnostic marker |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0672158B2 (ja) * | 1984-05-24 | 1994-09-14 | チバ−ガイギ− アクチエンゲゼルシヤフト | 精製されたヒトマクロファージ遊走阻止因子 |
US5008374A (en) * | 1986-03-14 | 1991-04-16 | Otsuka Pharmaceutical Co., Ltd. | IL-1α derivatives and drugs |
EP0263072B1 (de) * | 1986-10-03 | 1994-03-23 | Ciba-Geigy Ag | Lymphokin-ähnliche Peptide |
EP0761685A3 (de) * | 1987-10-02 | 1998-01-28 | The Rockefeller University | Von Makrophagen abstammender Entzündungsvermittler (mip-1 alpha und mip-1 beta) |
-
1989
- 1989-07-05 GB GB898915414A patent/GB8915414D0/en active Pending
-
1990
- 1990-06-26 AT AT90810481T patent/ATE131873T1/de not_active IP Right Cessation
- 1990-06-26 DE DE69024279T patent/DE69024279T2/de not_active Expired - Fee Related
- 1990-06-26 DK DK90810481.3T patent/DK0412050T3/da active
- 1990-06-26 ES ES90810481T patent/ES2081960T3/es not_active Expired - Lifetime
- 1990-06-26 EP EP90810481A patent/EP0412050B1/de not_active Expired - Lifetime
- 1990-07-02 AU AU58095/90A patent/AU649226B2/en not_active Ceased
- 1990-07-03 CA CA002020303A patent/CA2020303A1/en not_active Abandoned
- 1990-07-03 PT PT94575A patent/PT94575B/pt not_active IP Right Cessation
- 1990-07-03 DD DD90342467A patent/DD298948A5/de not_active IP Right Cessation
- 1990-07-04 IE IE242690A patent/IE70519B1/en not_active IP Right Cessation
- 1990-07-05 JP JP2176488A patent/JPH0356499A/ja active Pending
-
1991
- 1991-12-20 US US07/811,893 patent/US5411882A/en not_active Expired - Fee Related
-
1995
- 1995-12-21 GR GR950403656T patent/GR3018521T3/el unknown
-
1996
- 1996-09-27 US US08/714,927 patent/US5821336A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JPH0356499A (ja) | 1991-03-12 |
PT94575B (pt) | 1997-02-28 |
CA2020303A1 (en) | 1991-01-06 |
ES2081960T3 (es) | 1996-03-16 |
PT94575A (pt) | 1991-03-20 |
US5411882A (en) | 1995-05-02 |
US5821336A (en) | 1998-10-13 |
GR3018521T3 (en) | 1996-03-31 |
DD298948A5 (de) | 1992-03-19 |
EP0412050A1 (de) | 1991-02-06 |
GB8915414D0 (en) | 1989-08-23 |
AU5809590A (en) | 1991-01-10 |
DK0412050T3 (da) | 1996-01-29 |
DE69024279T2 (de) | 1996-10-17 |
EP0412050B1 (de) | 1995-12-20 |
ATE131873T1 (de) | 1996-01-15 |
AU649226B2 (en) | 1994-05-19 |
IE70519B1 (en) | 1996-12-11 |
IE902426A1 (en) | 1991-06-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69024279D1 (de) | Cytokine | |
ATE131872T1 (de) | Latenz assoziierte peptide und deren verwendung | |
EP1082433A4 (de) | Interleukine 21 und 22 | |
DE69630710D1 (de) | Humaner tumornekrosefaktor delta und epsilon | |
AU4688589A (en) | A method for treatment of endotoxic shock in a mammal | |
NL300008I1 (nl) | Tumornecrosis factor-alfa en -beta-receptors. | |
DE122004000003I1 (de) | Humane antikörper welche an humanen TNFalpha Binden. | |
IT8319234A0 (it) | Procedimento per la produzione di anticorpi monoclonali umani. | |
CY1109093T1 (el) | Πρωτεϊνες των υποδοχεων θηλαστικων, σχετικα αντιδραστηρια και σχετικες μεθοδοι | |
NO901046L (no) | Rekombinant proteinreseptor. | |
ATE490980T1 (de) | Der gemeinsamen gamma-kette ähnlicher zytokinrezeptor | |
HU9401511D0 (en) | Vaccine against streptococcus suls infection | |
KR900701318A (ko) | 항-사람 고분자량- 흑색종 관련 항원에 대한 항-이디오 타입 항체 | |
DE69504959D1 (de) | Humanisierte monoklonale antikörper gegen humanes interleukin - 4 | |
IT1231727B (it) | Peptidi utili per la determinazione e la purificazione di anticorpi anti gamma interferone. | |
DK592086A (da) | Humant conglutinin | |
WO2000017363A3 (en) | Interleukin-1 like molecule: interleukin-1-zeta; nucleic acids, polypeptides, antibodies, their uses | |
IT8747814A0 (it) | Apparecchio e procedimento per la finitura di pezzi cilindrici, quali pistoni e simili | |
DE59009360D1 (de) | Für das Plazentaprotein 9 (PP9) kodierende cDNA, ihre Isolierung und Verwendung. | |
ITTO911003A0 (it) | Metodo rapido per l'identificazione dello s.aureus, kit diagnostico per l'esecuzione di tale metodo, anticorpi monoclonali contro la glucosaminidasi dello s. aureus e ibridoma per la produzione di tali anticorpi. | |
BG48881A1 (en) | Hybridomic cell line mus musculus h 5/9, secretizing monoclonal antibodies against rickettsia conorii |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8327 | Change in the person/name/address of the patent owner |
Owner name: NOVARTIS AG, BASEL, CH |
|
8339 | Ceased/non-payment of the annual fee |